250 related articles for article (PubMed ID: 32682899)
1. Controlled drug delivery with nanoassemblies of redox-responsive prodrug and polyprodrug amphiphiles.
Deng Z; Liu S
J Control Release; 2020 Oct; 326():276-296. PubMed ID: 32682899
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory polymersomes of redox-responsive polyprodrug amphiphiles with inflammation-triggered indomethacin release characteristics.
Tan J; Deng Z; Liu G; Hu J; Liu S
Biomaterials; 2018 Sep; 178():608-619. PubMed ID: 29605185
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
4. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
5. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery.
Hu X; Hu J; Tian J; Ge Z; Zhang G; Luo K; Liu S
J Am Chem Soc; 2013 Nov; 135(46):17617-29. PubMed ID: 24160840
[TBL] [Abstract][Full Text] [Related]
6. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy.
Zhong W; Zhang X; Duan X; Liu H; Fang Y; Luo M; Fang Z; Miao C; Lin D; Wu J
Acta Biomater; 2022 May; 144():67-80. PubMed ID: 35331940
[TBL] [Abstract][Full Text] [Related]
8. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
9. Dimeric prodrug-based nanomedicines for cancer therapy.
Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
[TBL] [Abstract][Full Text] [Related]
11. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
[TBL] [Abstract][Full Text] [Related]
12. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating hyperbranched polyprodrug amphiphiles for synergistic reductive milieu-triggered drug release and enhanced magnetic resonance signals.
Hu X; Liu G; Li Y; Wang X; Liu S
J Am Chem Soc; 2015 Jan; 137(1):362-8. PubMed ID: 25495130
[TBL] [Abstract][Full Text] [Related]
14. Facile one-pot synthesis of amphiphilic acid/hypoxia co-triggered degradable diblock polyprodrug for tumor selective drug delivery.
Li X; Zhang J; Liu P
Int J Pharm; 2021 Sep; 606():120941. PubMed ID: 34324987
[TBL] [Abstract][Full Text] [Related]
15. Lipid Prodrug Nanoassemblies via Dynamic Covalent Boronates.
Ding Y; Hu X; Piao Y; Huang R; Xie L; Yan X; Sun H; Li Y; Shi L; Liu Y
ACS Nano; 2023 Apr; 17(7):6601-6614. PubMed ID: 36999933
[TBL] [Abstract][Full Text] [Related]
16. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment.
Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J
Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
[TBL] [Abstract][Full Text] [Related]
18. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.
Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z
J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976
[TBL] [Abstract][Full Text] [Related]
19. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
[TBL] [Abstract][Full Text] [Related]
20. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
